Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 2, 2014

Primary Completion Date

March 3, 2019

Study Completion Date

March 3, 2019

Conditions
Prostatic Hyperplasia, BenignProstatic Hypertrophy, BenignGenital Diseases, MaleLower Urinary Tract SymptomsProstatic Diseases
Interventions
PROCEDURE

Prostatic Arterial Embolization

"The prostatic arteries are selectively catheterized with a Progreat 2.7 microcatheter and an angiography is performed to confirm that the catheter is in the prostatic artery. Bead Block 300-500 or PVA 100+200 micra particles are slowly injected under fluoroscopic control until the end point is reached. Embolization is considered finished when there is near stasis in the prostatic vessels with interruption of the arterial flow and prostatic gland opacification checked in both oblique and AP views. Upon finishing the embolization of the left prostatic arteries, the right prostatic arteries are embolized in the same way."

PROCEDURE

Sham procedure

The prostatic arteries are selectively catheterized with a Progreat 2.7 microcatheter and an angiography is performed to confirm that the catheter is in the prostatic artery. The catheter is removed and no particles are injected.

Trial Locations (1)

1200-249 Lisboa

Hospital de Saint Louis, Lisbon

All Listed Sponsors
lead

João Martins Pisco

OTHER

NCT02074644 - Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter